CPRX EBITDA Margin
Catalyst Pharmaceuticals Inc · EBITDA Margin
CPRX EBITDA Margin
Latest reported56.06%period ending
CPRX EBITDA Margin (0.00% → 56.06%)
Annual ebitda margin
High-resolution chart · PNG
CPRX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 54.566% | |
| 51.6615% | |
| 31.9916% | |
| 49.4662% | |
| 37.5331% | |
| 34.7644% | |
| 31.1595% | |
| -7,051.4374% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -817.7471% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |